Insider Profile
Pickles, David Arthur
1
Companies Filed At
2
Open-Market Buys (2yr)
$33K
Buy Value (2yr, open-market)
Dec 31, 2025
Most Recent Trade
18
Credibility
Score
57%
Hit Rate
+2.4%
Avg 90d Return
+3.1%
Median 90d Return
14
Evaluated Trades
+14.3%
Best Trade
-10.7%
Worst Trade
Hit rate and returns are based on 14 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Date Company Role Nature Dir. Shares Price Value Score
Dec 31, 2025 $EMA
Emera
Plan / DRIP Buy 168 $60.68 $10K 81
May 12, 2025 $EMA
Emera
Open Market Buy 136 $60.09 $8K 81
Dec 31, 2024 $EMA
Emera
Plan / DRIP Buy 219 $48.84 $11K 81
Nov 15, 2024 $EMA
Emera
Open Market Buy 485 $50.50 $24K 81
Mar 31, 2024 $EMA
Emera
Plan / DRIP Buy 81 $46.74 $4K 81
Feb 28, 2024 $EMA
Emera
Comp. Grant Buy 1,949 $48.09 $94K 81
Feb 28, 2024 $EMA
Emera
Comp. Grant Buy 1,949 $48.09 $94K 81
Dec 31, 2023 $EMA
Emera
Plan / DRIP Buy 72 $48.03 $3K 81
Dec 31, 2023 $EMA
Emera
Plan / DRIP Buy 72 $48.03 $3K 81
Dec 31, 2023 $EMA
Emera
Plan / DRIP Buy 271 $52.58 $14K 81
Sep 30, 2023 $EMA
Emera
Plan / DRIP Buy 64 $51.46 $3K 81
Sep 30, 2023 $EMA
Emera
Plan / DRIP Buy 64 $51.46 $3K 81
Jun 30, 2023 $EMA
Emera
Plan / DRIP Buy 55 $58.78 $3K 81
Jun 30, 2023 $EMA
Emera
Plan / DRIP Buy 55 $58.78 $3K 81
Feb 28, 2023 $EMA
Emera
Other Sell 1,566 $51.66 $81K 81
Feb 27, 2023 $EMA
Emera
Other Sell 1,566 $51.66 $81K 81
Dec 31, 2022 $EMA
Emera
Plan / DRIP Buy 186 $59.53 $11K 81
Feb 23, 2022 $EMA
Emera
Other Sell 1,494 $59.77 $89K 81
Feb 23, 2022 $EMA
Emera
Other Sell 1,494 $59.77 $89K 81
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Signal scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.